Reporter Zhang Xiaoyu
Recently, the demand for family standing medicines for epidemic prevention and protection has surged. According to the data of Baidu search index, the recent keywords such as "fever", "cough and expectoration", "ibuprofen", "Lianhua Qingwen" and "Pudilan" The search index has entered a stage of rapid improvement, and the production capacity of pharmaceutical source manufacturers has also attracted much attention.
What is the production situation of anti-epidemic and protective drugs, and can the market supply be guaranteed?
Pharmaceutical companies ramp up production
In response to the above problems, the reporter contacted Yiling Pharmaceutical, the manufacturer of Lianhua Qingwen, to investigate the production situation of Lianhua Qingwen.
On the morning of December 21, in the production workshop of Yiling Pharmaceutical Lianhua Qingwen Granules, more than a dozen automated production lines were running at high speed. Boxes of Lianhua Qingwen Granules were scanned and packed, a busy scene...
The staff of the Lianhua Qingwen capsule workshop are also constantly busy.
Whether the batch number is printed completely, whether there are burrs on the aluminum-plastic plate, whether the embossing of the aluminum-plastic plate is clear...the machine inspectors and sampling inspectors strictly check to ensure the quality of medicines.
"We have built a quality management system of 'full variety, all-round, whole process, full coverage, and full personnel' and a full life cycle, creating a quality system model of interlocking and closed-loop management." Wang Gang, quality director of Yiling Pharmaceutical, told Reporter, since the production rush, all the quality department staff have been on duty to strictly control the "seven checks" of drugs, so as to ensure the quality of each batch of products and ensure the safety of medication.
Zhang Yunling, executive deputy general manager of Yiling Pharmaceutical, introduced: "With the continuous improvement of market demand, we responded quickly and followed the management of 'tight and orderly, busy but not chaotic, checking at all levels, ensuring quality, and safe production'" In principle, take various measures, adjust the production line in time, and put full power into the production rush of Lianhua Qingwen. At present, the three production bases in Shijiazhuang, Hengshui, and Beijing meet the normal operation of the company's other drugs, and the rest of the production lines are fully equipped. It is used in the production of Lianhua Qingwen series products, which greatly improves the production capacity, and fully meets the market demand with quality and quantity. Moreover, the supply price of Lianhua Qingwen capsules (granules) has remained stable recently.”
Facing the situation of "Lianhua Qingwen is in short supply" in the market, Zhang Yunling also explained: "The temporary shortage of goods in some areas is related to various factors such as whether the local logistics is smooth and whether the goods are on the shelves in pharmacies in a timely manner. As Manufacturers, we will always do our best to ensure the supply of medicines according to market demand now and in the future, and do our best to meet the health needs of the general public."
In addition to the Lianhua Qingwen production company increasing its production capacity to ensure supply, ibuprofen and acetaminophen preparation companies are also gradually releasing production capacity.
Xinhua Pharmaceutical stated on the interactive platform on December 21 that the company is actively cooperating with the relevant requirements of the national epidemic prevention policy, working overtime to produce urgently needed drugs in the market, and making every effort to ensure market supply.
Northeast Pharmaceutical announced on December 20 that the market demand for antipyretic and analgesic drugs has recently increased. The company adheres to the mission of "pharmaceuticals for the country" and accelerates the production of acetaminophen tablets and compound paracetamol tablets according to market demand. And vitamin C series preparation products, fully guarantee the market supply.
Teyi Pharmaceuticals stated on the investor interaction platform on December 19 that according to the "Medication Catalog for Patients Infected with New Coronavirus (First Edition)", the company's acetaminophen tablets, ibuprofen tablets, and diclofenac sodium enteric-coated tablets are applicable For fever symptoms, compound acetaminophen capsules are suitable for cold symptoms such as fever, runny nose, nasal congestion, and sneezing.
At present, the sales of the above-mentioned products are in good condition, and the company has been producing at full capacity to ensure market demand.
The supply of raw materials is guaranteed
In the face of rapidly growing market demand, will there be a shortage of raw materials for the production of Lianhua Qingwen?
Zhang Yunling said: "The company's main raw materials have strategic stocks, which can cope with the surge in consumption."
"Chinese medicinal materials have certain attributes of agricultural products, and are affected by various factors such as weather, natural environment, growth cycle, and market supply and demand. The company has established a safety stock early warning system for strategic varieties to monitor the stock of Chinese medicinal materials in real time to ensure that the products are normal. Production. And the company has multiple self-built and co-built raw material planting and processing bases, as well as core suppliers, which can guarantee normal supply. The production capacity of other auxiliary materials and packaging material suppliers has increased rapidly, and the supply can be guaranteed.” Zhang Yunling further Said.
"Taking Forsythia as an example, it is one of the main components of Lianhua Qingwen. In recent years, the company has vigorously promoted the development of Forsythia in the Taihang Mountains industrial belt, from the selection and breeding of fine varieties, standardized planting management, standardized processing, comprehensive Utilization and other aspects have been vigorously promoted, and three bases have been established in Shexian County, Handan City, Wu'an City, and Jingxing County, Shijiazhuang City, and the planting area of forsythia has reached more than 100,000 mu." Zhang Yunling said that in addition to forsythia, the production of Lianhua Qingwen is required There are planting bases for original medicinal materials such as honeysuckle and isatis root, which will continue to meet the production needs of Lianhua Qingwen with quality and quantity.
In addition to the guaranteed supply of Chinese medicinal materials, the production capacity of raw materials such as ibuprofen can also meet the demand.
According to data from the State Food and Drug Administration, there are currently 194 types of antipyretic, cough, antibacterial, and antiviral drugs that have been marketed in my country, involving more than 9,000 approval numbers.
Judging from the research of some enterprises, the raw material drug production capacity of ibuprofen and acetaminophen in my country is relatively sufficient, which can meet the domestic demand for preparation production.
Since October, sales of Ibuprofen Granules, Nimesulide Granules, Amphenol Huangmin Granules, Levocetirizine Granules, Ganmao Qingre Granules, and Zhike Juhong Granules have surged.
Kang Zhi Pharmaceutical also stated during the investor survey that the company has guaranteed smooth production. The company's production base has adopted methods such as coordinating internal resources, adjusting production schedules to implement a multi-shift system, expanding production lines, and actively seeking external support to rapidly increase production capacity. Basically, the market supply can be guaranteed one after another.
In terms of raw material storage, the company coordinates with the upstream to ensure supply, and allocates equipment from the group to the Hainan base. The original equipment in the Hainan base is operating in multiple shifts.